According to T2 Biosystems 's latest financial reports the company's current EPS (TTM) is -HK$2,225. In 2022 the company made an earnings per share (EPS) of -HK$8,865 a decrease over its 2021 EPS that were of -HK$235.96.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -HK$2,247 | -74.66% |
2022 | -HK$8,865 | 3657.07% |
2021 | -HK$235.96 | -28.16% |
2020 | -HK$328.47 | -63.02% |
2019 | -HK$888.15 | 3.62% |
2018 | -HK$857.13 | -34.42% |
2017 | -HK$1,307 | -20.52% |
2016 | -HK$1,644 | -3.64% |
2015 | -HK$1,706 | -4.41% |
2014 | -HK$1,785 | 37.82% |
2013 | -HK$1,295 |